The role of matrix metalloproteinases in leukocyte migration and collagen degradation in tuberculosis
File(s)
Author(s)
Sathyamoorthy, Tarangini
Type
Thesis
Abstract
Tuberculosis (TB) causes disease worldwide and multi-drug resistance is rising. Matrix metalloproteinases (MMPs) cause immunopathological lung matrix destruction, which results in transmission, morbidity and mortality. Collagen is the primary structural fibril of the lung and I primarily studied two collagenases: secreted MMP-8, and membrane bound MMP-14, and also the stromelysin MMP-10, which activates not only MMP-8 but another collagenase MMP-1.
Human monocyte and macrophages were stimulated with Mtb H37Rv, BCG, ESAT-6 peptides or Conditioned Media from Mtb infected monocytes (CoMTb). MMP concentrations were measured by Luminex bead array and ELISA. Gene expression was quantified by RT-PCR. Immunohistochemistry was performed on biopsies. Flow cytometry quantified MMP-14 expression. Fluorescent microscopy detected MMP-14 and monocyte driven fluorescent collagen degradation. Monocyte migration was measured by the agarose spot assay.
MMP-8 was increased in the plasma in TB compared to both respiratory symptomatics and controls (both p<0.001). MMP-10 was increased in the respiratory secretions of patients with TB compared to controls (p<0.05). Mtb drove up to a 31.5 fold increase in MMP-10 secretion from macrophages (both p<0.001). Mtb caused 3.5 fold more MMP-10 secretion from macrophages than BCG (p<0.001) and a specific peptide from ESAT-6 drove MMP-10 secretion from macrophages. In induced sputum, MMP-14 mRNA was increased 3.3-fold in TB compared to controls and positively correlated with infiltration on chest radiograph (both p<0.05). Macrophages of TB granulomas in biopsies stained strongly positive for MMP-14. Mtb increased monocyte MMP-14 surface expression 31.7-fold (p<0.05) and CoMTb 17.5-fold (p<0.01). Mtb infected monocytes degraded collagen, with co-localised MMP-14 surface expression. Monocytes migrated to the edge of CoMTb impregnated agarose drops, expressing MMP-14 on migration. Inhibition of MMP-14 activity with a neutralising antibody, decreased Mtb driven collagen degradation by 73% (p< 0.001) and CoMTb driven monocyte migration by 44% (p<0.001).
These data shows that, MMP-1, -8, -10 and -14 cause immunopathology and regulate leukocyte migration in TB.
Human monocyte and macrophages were stimulated with Mtb H37Rv, BCG, ESAT-6 peptides or Conditioned Media from Mtb infected monocytes (CoMTb). MMP concentrations were measured by Luminex bead array and ELISA. Gene expression was quantified by RT-PCR. Immunohistochemistry was performed on biopsies. Flow cytometry quantified MMP-14 expression. Fluorescent microscopy detected MMP-14 and monocyte driven fluorescent collagen degradation. Monocyte migration was measured by the agarose spot assay.
MMP-8 was increased in the plasma in TB compared to both respiratory symptomatics and controls (both p<0.001). MMP-10 was increased in the respiratory secretions of patients with TB compared to controls (p<0.05). Mtb drove up to a 31.5 fold increase in MMP-10 secretion from macrophages (both p<0.001). Mtb caused 3.5 fold more MMP-10 secretion from macrophages than BCG (p<0.001) and a specific peptide from ESAT-6 drove MMP-10 secretion from macrophages. In induced sputum, MMP-14 mRNA was increased 3.3-fold in TB compared to controls and positively correlated with infiltration on chest radiograph (both p<0.05). Macrophages of TB granulomas in biopsies stained strongly positive for MMP-14. Mtb increased monocyte MMP-14 surface expression 31.7-fold (p<0.05) and CoMTb 17.5-fold (p<0.01). Mtb infected monocytes degraded collagen, with co-localised MMP-14 surface expression. Monocytes migrated to the edge of CoMTb impregnated agarose drops, expressing MMP-14 on migration. Inhibition of MMP-14 activity with a neutralising antibody, decreased Mtb driven collagen degradation by 73% (p< 0.001) and CoMTb driven monocyte migration by 44% (p<0.001).
These data shows that, MMP-1, -8, -10 and -14 cause immunopathology and regulate leukocyte migration in TB.
Version
Open Access
Date Issued
2013-12
Date Awarded
2014-07
Copyright Statement
Attribution NoDerivatives 4.0 International Licence (CC BY-ND)
Advisor
Friedland, Jon
Elkington, Paul
Sponsor
Medical Research Council (Great Britain)
Grant Number
G0900429
Publisher Department
Medicine
Publisher Institution
Imperial College London
Qualification Level
Doctoral
Qualification Name
Doctor of Philosophy (PhD)